The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel

Histopathology

Volumn 28, Issue 6, 1996, Pages 497-512

  Cook, M G ⁱ   Clarke, T J ^a   Humphreys, S ^b   Fletcher, A ^c   McLaren, K M ^d   Smith, N P ^e   Stevens, A ^f   Theaker, J M ^g   Melia, J ^h  

^a Area Department of Pathology   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f QUEEN S MEDICAL CENTRE   (United Kingdom)

^g SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Evaluation studies; Melanoma; Pathology; Prognosis; Terminology

Indexed keywords

ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA IN SITU; PRIORITY JOURNAL; PROGNOSIS; SKIN CANCER;

EID: 0029897215     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-464.x     Document Type: Article

References (40)

1. Graham-Brown RAC, Osborne JE, London SP et al. The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br. J. Dermatol. 1990; 122; 53-59.
2. Mackie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br. Med. J. 1992; 504; 1012-1015.
3. Whitehead SM, Wroughton MA, Elwood JM, Davison J, Stewart M. Effects of a health education campaign for the earlier diagnosis of melanoma. Br. J. Cancer 1989; 60; 421-425.
4. Williams HC, Smith D, du Vivier AWP. Evaluation of public education campaigns in cutaneous melanoma: The King's College Hospital experience. Br. J. Dermatol. 1990; 123; 85-92.
5. Ellman R. Screening for melanoma in the UK. In Miller AB, Chamberlain J, Day NE, Hakama M, Prorok RC eds. Cancer Screening. UICC Project on Evaluation of Screening for Cancer. Cambridge University Press, 1991; 257-266.
6. Kopf AW, Minzis M, Bart RS. Diagnosis accuracy in malignant melanoma. Arch. Dermatol. 1975; 3; 1291-1292.
7. Rampen FHJ, Rumke P. Referral pattern and accuracy of clinical diagnosis of cutaneous melanoma. Acta. Derm. Venerol. (Stockh.) 1988; 86; 61-64.
8. van der Esch EP, Muir CS, Nectoux J et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int. J. Cancer 1991; 47; 483-490.
9. Philipp R, Hastings A, Briggs J, Sizer J. Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions? J Epidemiol. Community Health 1987; 42; 14-16.
10. Clemente C, Cochran At, Elder DE et al. Histopathologic diagnosis of dysplastic naevi. Human Path. 1991; 22; 313-319.
11. Hastrup N, Clemmonsen OJ, Spaun E, Sondergaard K. Dysplastic naevi: histologic criteria and their inter-observer reproducibility. Histopathology 1994; 24; 503-509.
12. de Wit PEJ, Van't Hof-Grootenboer B, Ruiter DJ et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. Eur. J. Cancer 1993; 29a; 831-839.
13. Steijlen PM, Bergman W, Hermans J, Schaffer E, van Vloten WA, Ruiter DJ. The efficacy of histopathological criteria required for diagnosing dysplastic naevi. Histopatholopgy 1988; 12; 289-300.
14. Clark WH Jr, Elder DE, Guerry IV D, Braitman LE et al. Model predicting survival in Stage I melanoma based on tumour progression. J. Natl. Cancer Inst. 1989; 81; 1893-1904.
15. Cook MG. The significance of inflammation and regression in melanoma. Virchows Archiv A. 1992; 420; 113-115.
16. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of Surgery 1970; 182; 902-908.
17. Kirkham N, Cotton DWK. Measuring Melanomas. The Vernier Method. J. Clin. Pathol. 1984; 36; 2291.
18. Phillips ME, Margolis RJ, Merot Y et al. The spectrum of minimal deviation melanoma: a clinicopathological study of 21 cases. Hum. Path. 1986; 17; 796-806.
19. Wong T-Y, Susters S, Duncan LM, Mihm MC. Nevoid melanoma. A clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelial cell nevus and verrucous dermal nevus. Hum. Path. 1995; 26; 171-179.
20. Haupt HM, Stern JB. Pagetoid melanocytosis, Histiologic features in benign and malignant lesions. Am. J. Surg. Path. 1995; 19; 792-797.
21. Kallowfield ME, Cook MG. Pagetoid infiltration in primary cutaneous melanoma. Histopathology 1992; 20; 417-420.
22. Elder DE, Murphy GF. Malignant tumours (melanomas and related lesions). In Rosai J ed. Melanocytic Tumors of the Skin. Vol. 2. Atlas of Tumor Pathology. Washington: AFIP, 1991; 103-205.
23. Cohen FA. A coefficient of agreement for nominal scales. Ed. Psychol. Measuremenets 1960; 20; 37-46.
24. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley, 1981.
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33; 159-74.
26. Duray PH, Dersimonioan R, Barnhill R et al. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J. Am. Academ. Dermatol. 1992; 27; 741-749.
27. Klein LJ, Barr RJ. Histologic atypia in clinically benign naevi. JAAD 1990; 22; 275-282.
28. Kang S, Barnhill RL, Mihm MC Jr, Sober AJ. Histologic regression in malignant melanoma: an interobserver concordance study. J. Cutan. Pathol. 1993; 20; 1126-1129.
29. Colloby PS, West KP, Fletcher A. Obsever variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J. Pathology 1991; 163; 245-250.
30. Prade M, Sanch-Garnier H, Cesarini JP, Cochran A. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous melanoma. Int. J. Cancer 1980; 26; 159-163.
31. Heenan PJ, Matz LR, Blackwell JB et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia. Histopathol. 1984; 8; 717-729.
32. Swanson-Beck J. & Members of MRC Breast Tumour Pathology Panel. Observer variability in reporting of breast lesions. J. Clin. Pathol. 1985; 38; 1358-1365.
33. Robertson AJ, Anderson JM, Swanson-Beck et al. Observer variability in histopathological reporting of cervical biopsy specimens. J. Clin. Pathol. 1989; 42; 231-238.
34. Malec E, Eklund G, Lagerlof B. Re-appraisal of malignant diagnosis in the Swedish Cancer Registry. Acta Pathol. Microbiol. Scand. (A) 1977; 85; 707-712.
35. Reed RJ. The histological variance of malignant melanoma: the McGovern VJ. Spontaneous regression of melanoma. Histopathology 1975; 7; 91-99.
36. Szymik B, Woosley JT. Further validation of the prognostic model for Stage I malignant melanoma based on tumour progression. J. Cutan. Pathol. 1993; 20; 50-53.
37. Rowley MJ, Cockerell CJ. Reliability of prognostic models in malignant melanoma. A 10 yr follow-up study. Am. J. Dermatopath. 1991; 13; 431-437.
38. Mansson-Brahme E, Corstensen J, Erhardt K, Lagerhof B, Ringborg U, Rutquist LE. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994; 73; 2324-2332.
39. Kerl H, Hodl S, Stettnen H. Acral lentiginous melanoma. In Ackerman AB ed. Pathology of Malignant Melanoma. Vol. 1. Masson: New York: 1981; 217.
40. Sagebiel RW. Histopathology of precursor melanocytic lesions. Am. J. Surg. Path., 1985; 9 suppl.: 41-51.